BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10987436)

  • 21. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
    Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcimimetics as a new chance for effective treatment of calcium metabolism disturbances].
    Nowak Z; Laudański K
    Pol Merkur Lekarski; 2002 Nov; 13(77):424-7. PubMed ID: 12621766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium-Sensing Receptor: Trafficking, Endocytosis, Recycling, and Importance of Interacting Proteins.
    Ray K
    Prog Mol Biol Transl Sci; 2015; 132():127-50. PubMed ID: 26055057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacoperones and the calcium sensing receptor: exogenous and endogenous regulators.
    Breitwieser GE
    Pharmacol Res; 2014 May; 83():30-7. PubMed ID: 24291533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcium-sensing receptor and its related diseases].
    Aida K; Tawata M; Onaya T
    Nihon Rinsho; 1999 Mar; 57(3):746-55. PubMed ID: 10199162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
    Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcimimetics].
    Messa P; Como G; Brezzi B
    G Ital Nefrol; 2006; 23(1):12-21. PubMed ID: 16521071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The extracellular calcium sensing receptor is expressed in mouse mesangial cells and modulates cell proliferation.
    Kwak JO; Kwak J; Kim HW; Oh KJ; Kim YT; Jung SM; Cha SH
    Exp Mol Med; 2005 Oct; 37(5):457-65. PubMed ID: 16264270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of arachidonic acid and glutamate in the formation of inositol phosphates induced by noradrenalin in striatal astrocytes.
    Marin P; Stella N; Cordier J; Glowinski J; Prémont J
    Mol Pharmacol; 1993 Dec; 44(6):1176-84. PubMed ID: 7903416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcimimetics with potent and selective activity on the parathyroid calcium receptor.
    Nemeth EF; Steffey ME; Hammerland LG; Hung BC; Van Wagenen BC; DelMar EG; Balandrin MF
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):4040-5. PubMed ID: 9520489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator].
    Nagano N; Tsutsui T
    Clin Calcium; 2016 Jun; 26(6):839-50. PubMed ID: 27230839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.
    Dickenson JM; Hill SJ
    Br J Pharmacol; 1995 Dec; 116(7):2889-96. PubMed ID: 8680721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of adenosine A1 receptor-mediated inositol phospholipid hydrolysis by tyrosine kinase inhibitors in CHO cells.
    Dickenson JM; Hill SJ
    Br J Pharmacol; 1998 Nov; 125(5):1049-57. PubMed ID: 9846644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of gill Ca2+-sensing receptor as a protective pathway to reduce Ca2+-induced cytotoxicity.
    Gu J; Law AY; Yeung BH; Wong CK
    J Mol Endocrinol; 2014 Oct; 53(2):155-64. PubMed ID: 25180251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic use of calcimimetics.
    Hebert SC
    Annu Rev Med; 2006; 57():349-64. PubMed ID: 16409154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of uremic bone disease using calcimimetic compounds.
    Olgaard K; Lewin E
    Annu Rev Med; 2001; 52():203-20. PubMed ID: 11160775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors.
    Vanderheyden PM; Verheijen I; Fierens FL; DeBacker JP; Vauquelin G
    Pharm Res; 2000 Dec; 17(12):1482-8. PubMed ID: 11303957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic stimulation of inositol phosphate formation in bovine adrenal chromaffin cells: distinct nicotinic and muscarinic mechanisms.
    Eberhard DA; Holz RW
    J Neurochem; 1987 Nov; 49(5):1634-43. PubMed ID: 3668543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-Sensing Receptor Stimulation in Cultured Glomerular Podocytes Induces TRPC6-Dependent Calcium Entry and RhoA Activation.
    Zhang L; Ji T; Wang Q; Meng K; Zhang R; Yang H; Liao C; Ma L; Jiao J
    Cell Physiol Biochem; 2017; 43(5):1777-1789. PubMed ID: 29050010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium sensing receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: correlation with osteogenic differentiation.
    Pipino C; Di Tomo P; Mandatori D; Cianci E; Lanuti P; Cutrona MB; Penolazzi L; Pierdomenico L; Lambertini E; Antonucci I; Sirolli V; Bonomini M; Romano M; Piva R; Marchisio M; Pandolfi A
    Stem Cells Dev; 2014 Dec; 23(24):2959-71. PubMed ID: 25036254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.